Table 4 Levels of biomarkers in improved vs non-improved iNPH patents (median and IQ-range)
From: Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus
Improved | Non-improved | ||
|---|---|---|---|
n = 10 | n = 10 | ||
NFL (ng/L) | 1186 (869–1670) | 1085 (699–2432) | ns |
APL1β25 (ng/L) | 2532 (2174–2958) | 2820 (2401–2954) | ns |
APL1β27 (ng/L) | 1067 (900–1157) | 1085 (867–1214) | ns |
APL1β28 (ng/L) | 1423 (1264–1568) | 1458 (1291–1562) | ns |
Aβ38 (ng/L) | 500 (308–605) | 503 (224–677) | ns |
Aβ40 (ng/L) | 3731 (2642–4740) | 3677 (1522–4789) | ns |
Aβ42 (ng/L) | 241 (155–370) | 244 (122–438) | ns |
sAPPα (ng/mL) | 205 (175–279) | 212 (144–297) | ns |
sAPPβ (ng/mL) | 114 (95–155) | 127 (75–181) | ns |
YKL40 (ng/mL) | 122 (99–153) | 134 (84–180) | ns |